New findings from the SURMOUNT-4 trial showed that participants using tirzepatide lost more than a quarter of their body weight, results on par with bariatric surgery. “This has been a goal of many people in the field of medical treatment of obesity, to achieve the same amount of weight loss as achieved by our surgical colleagues,” said Dr. Louis Aronne, Intellihealth co-founder.
Read more at Healio